Boxer Capital’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,200,000
Closed -$23M 82
2023
Q1
$23M Hold
3,200,000
1.13% 29
2022
Q4
$26.3M Hold
3,200,000
1.39% 27
2022
Q3
$33.8M Hold
3,200,000
1.9% 17
2022
Q2
$29.6M Hold
3,200,000
1.87% 21
2022
Q1
$22M Hold
3,200,000
1.13% 27
2021
Q4
$25.8M Buy
3,200,000
+225,000
+8% +$1.49M 1% 27
2021
Q3
$18.3M Hold
2,975,000
0.64% 46
2021
Q2
$9.25M Hold
2,975,000
0.33% 67
2021
Q1
$11.4M Hold
2,975,000
0.39% 58
2020
Q4
$9.1M Hold
2,975,000
0.29% 57
2020
Q3
$6.75M Buy
2,975,000
+1,200,000
+68% +$3.4M 0.23% 61
2020
Q2
$18.3M Hold
1,775,000
0.8% 33
2020
Q1
$17.7M Hold
1,775,000
1.21% 25
2019
Q4
$13.5M Hold
1,775,000
0.76% 33
2019
Q3
$11.3M Buy
+1,775,000
New +$12.5M 0.82% 29

Other funds holding BLU

Boxer Capital's BLU Position: Q2 2023 in Review

Boxer Capital sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 3,200,000 shares — an estimated $23M sold.

Boxer Capital first reported a position in BLU in Q3 2019 and held it in 15 quarters. The position peaked at $33.8M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Boxer Capital reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Boxer Capital sold 3,200,000 BELLUS Health Inc. shares in Q2 2023, an estimated $23M.
  • Boxer Capital first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 15 quarters.
  • Boxer Capital's BELLUS Health Inc. position peaked at $33.8M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Boxer Capital's 13F filing for Q2 2023, filed 14 Aug 2023.